Categories

ESFRI releases new report on research infrastructures

By . Published on 18 July 2011 in:
News, , ,

The European Strategy Forum on Research Infrastructures (ESFRI) have released their Strategy Report and Roadmap Update 20101. The chair of ESFRI, Beatrix Vierkorn-Rudolph presented the roadmap to the European Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn, in Brussels on 3 May this year.

“Pooling national and EU resources to build pan-European research infrastructures – rather than each Member State simply going it alone – is common sense and a key part of the EU’s Innovation Union plan,” said Geoghegan-Quinn. “These collaborative efforts create economies of scale, boost EU competitiveness and deliver better value for money for taxpayers.”

The report consists of two main parts – the work programme of ESFRI for the upcoming years, and a roadmap which illustrates 48 Europe-wide Research Infrastructures and major upgrades which will meet the needs of research communities in the European Union for the next 10-20 years. The updated roadmap contains six new projects – three in the area of biological and medical sciences, and three in the field of energy.

ESFRI – which was established by the European Commission in 2002 – exists to support the development and operation of research infrastructures, at a European and international level.

Vierkorn-Rudolph will also be penning an article on the roadmap, to be published in an upcoming issue of EPN.

  1. doi:10.2777/23127 []



Read previous post:
First Bern Cyclotron Symposium

The first Bern Cyclotron Symposium took place on 6-7 June this year in Bern, Switzerland. The event featured review talks from international experts on research with medical accelerators, with an emphasis on activities at the new Bern Cyclotron Laboratory.

The symposium is sponsored by: ANS Architekten und Planer, Berthold Technologies, Dehnel Particle Accelerator Components and Engineering, IBA, NEST Consulting, SWAN Isotopen, Tema Sinergie and Zyklotron; with support from...

Close
chemist